Welcome to our dedicated page for Applied UV news (Ticker: AUVI), a resource for investors and traders seeking the latest updates and insights on Applied UV stock.
Applied UV, Inc. (NASDAQ: AUVI), founded in 2012, is a pioneering company headquartered in Mount Vernon, New York. The company specializes in the design, manufacture, assembly, and distribution of automated disinfecting mirror systems, primarily for hospitals and healthcare facilities. They also create and supply custom-designed decorative framed mirrors, framed art, and bathroom vanities, catering mainly to the hospitality sector. Applied UV operates extensively across the United States and internationally.
The company's recent achievements include the launch of the Fighter Flex LED solution, which showcases advanced energy efficiency for HVAC systems. This technology, selected by the GSA and DOE for the Green Proving Ground Program, promises substantial energy savings by maintaining HVAC coil efficiency. The patented UVC LED system that Applied UV has developed can reduce energy consumption in HVAC systems by 5-15%, translating to approximately $45,000 in annual savings for a 100,000 square foot office space.
Applied UV is also making significant strides with its Smart Building Technologies division, which is expected to generate substantial revenue. With strategic investments and distribution agreements, the division anticipates a $10 million contribution from just three major accounts in 2024.
Expanding its horizon, Applied UV has engaged in a multi-year exclusive global licensing agreement with Element Designs to enhance outdoor systems for commercial and public spaces. This partnership will incorporate smart building technologies to further reduce energy consumption and enhance visual appeal.
The company’s disinfection technology, particularly the PURONet Control System, integrates continuous and terminal disinfection methods to ensure optimal cleanliness in healthcare settings. This innovative system is especially significant for operating rooms, providing a seamless switch between continuous low-level disinfection and deep terminal cleaning.
Moreover, Applied UV has entered the hospitality market with its plans for Larimar City & Resort in the Dominican Republic, expected to generate $250 million to $300 million over 3-6 years. This multi-use development will benefit from Applied UV’s custom interiors and smart energy-saving solutions.
In March 2024, the company announced a patent application for a disinfection system utilizing multiple wavelengths, enhancing its already robust portfolio of healthcare solutions. This system aims to optimize environmental cleanliness, particularly in healthcare facilities.
Overall, Applied UV continues to drive innovation and develop smart building technologies across healthcare, hospitality, commercial, and municipal markets.
Applied UV, Inc. (NASDAQ: AUVI) has signed a Master Distributor agreement with FSG, a leading U.S. lighting distributor, to enhance its SteriLumen portfolio of disinfection devices. FSG's strong sales in the disinfection market, exceeding $10 million in 2020, are expected to complement Applied UV’s offerings. The partnership will cover distribution, logistics, and technical support for products that target infections on surfaces and air purification. This collaboration reinforces Applied UV's commitment to addressing healthcare-acquired infections and improving air quality across various sectors.
Applied UV (NASDAQ:AUVI) has secured orders over $850,000 for its Airocide® air purification systems from 3Sixty Biopharmaceuticals, a leading distributor in Africa. This order is part of a $3.5 million minimum purchase commitment for the first year. The Airocide® technology, originally developed by NASA, effectively eliminates airborne pathogens and is FDA Class II listed. CEO Q Saeed expressed confidence in 3Sixty's capability to enhance Airocide®'s market presence across Africa.
Applied UV, Inc. (NASDAQ: AUVI) announced that independent lab tests confirmed its SteriLumen Lumicide™ Ribbon effectively kills SARS-CoV-2, the virus causing COVID-19. Conducted by CUBRC, Inc., the study showed over 99.9% viral inactivation on stainless steel and ceramic surfaces within 5 to 20 minutes of exposure. These results bolster confidence in SteriLumen's technology for infection control in high-traffic areas such as healthcare and hospitality settings. CEO Q Saeed emphasized the antimicrobial efficacy of the product, further validating its role in combating pathogens.
Applied UV, Inc. (AUVI) announced an exclusive distribution agreement with Viet My Instrument and Technology Joint Stock Company for Airocide® air purification systems in Vietnam. The distributor commits to purchasing at least 100 consumer and 45 commercial systems in the first year. As Vietnam's healthcare spending is projected to grow significantly, Applied UV aims to expand its presence in this high-growth market. The Airocide® technology is known for its effectiveness in eliminating airborne pathogens and has applications in various sectors such as healthcare and hospitality.
Applied UV, Inc. (AUVI) announced the installation of 50 Airocide® Systems at the MUNDUS VINI 2021 wine competition, enhancing air quality for over 300 international wine experts. This initiative demonstrates the growing demand for advanced air purification technologies, particularly in the wine industry. Airocide®, developed with NASA's assistance, effectively eliminates airborne pathogens and is recognized as an FDA Class II Medical device. CEO Q Saeed emphasized the importance of safety measures in re-opening live events amid Covid-19 challenges.
Applied UV has successfully installed 60 Airocide® units in Colegio Santa Elena, Uruguay, as part of its international expansion strategy. This installation follows a $3.5 million first-year purchase commitment from a South African distributor. The Airocide® technology, designed for pathogen elimination, enhances air quality in school settings, helping to combat the effects of remote learning and supporting a return to full attendance. The project is positioned as a prototype for broader implementation across South American schools.
Applied UV (NASDAQ:AUVI) has signed an exclusive distribution agreement with 3Sixty Biopharmaceuticals for the Airocide® air purification systems in Africa. 3Sixty commits to a minimum purchase of $3.5 million in the first year. The partnership aims to enhance air and surface infection control, crucial amid pandemic challenges. The Airocide® technology, originally developed by NASA, is clinically proven to eliminate airborne pathogens and is FDA Class II certified. This agreement sets the stage for potential future product expansions.
Applied UV, Inc. (NASDAQ:AUVI) announced a significant revenue increase of 157.1% in Q1 2021, reaching $2.31 million, driven by the acquisition of Akida Holdings. Despite this growth, the company reported a net loss of $1.03 million, attributed to higher SG&A costs. The firm also emphasized its strategic investments in new technologies and innovation, asserting a strong market position with broad adoption of its Airocide® system across industries. Liquidity remained solid, with a cash balance of $8.9 million as of March 31, 2021.
Applied UV (NASDAQ:AUVI) will host an investor conference call and live webcast on May 17, 2021, at 8:30 am EDT to discuss its Q1 2021 financial results. The results will be accessible through the Investor Relations section of their website. Interested participants can join via a link on Applied UV's site or by dialing +1-888-506-0062 for domestic callers. A replay will be available for a week post-call. Applied UV is a leader in infection control technology, emphasizing UVC solutions for various sectors.
Applied UV, Inc. (AUVI) announced the grant of a patent for its pathogen-destroying device by the Chinese Patent Office, adding to its growing intellectual property portfolio. This marks the tenth patent secured for their UVC-based disinfection technology, which aims to combat the global challenge of infection control. The company currently holds eight patents in the U.S., one in the EU, and one in China, with additional applications pending in various countries. The CEO emphasized the importance of patents in maintaining a competitive advantage and addressing healthcare-acquired infections.
FAQ
What is the current stock price of Applied UV (AUVI)?
What is the market cap of Applied UV (AUVI)?
What does Applied UV, Inc. specialize in?
What is the Fighter Flex LED solution?
Where is Applied UV, Inc. headquartered?
What markets does Applied UV serve?
What recent partnerships has Applied UV entered into?
What is the PURONet Control System?
What is the significance of the Larimar City & Resort project?
How does Applied UV's UVC LED technology benefit HVAC systems?
What recent patent application did Applied UV file?
How is Applied UV contributing to energy efficiency?
